Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.

Vigo T, La Rocca C, Faicchia D, Procaccini C, Ruggieri M, Salvetti M, Centonze D, Matarese G, Uccelli A; MSRUN Network.

Cell Death Dis. 2019 Jan 28;10(2):85. doi: 10.1038/s41419-019-1336-4.

2.

Vascular endothelial growth factor biology for regenerative angiogenesis.

Uccelli A, Wolff T, Valente P, Di Maggio N, Pellegrino M, Gürke L, Banfi A, Gianni-Barrera R.

Swiss Med Wkly. 2019 Jan 27;149:w20011. doi: smw.2019.20011. eCollection 2019 Jan 14.

3.

Tocilizumab in MOG-antibody spectrum disorder: a case report.

Novi G, Gastaldi M, Franciotta D, Pesce G, Benedetti L, Uccelli A.

Mult Scler Relat Disord. 2019 Jan;27:312-314. doi: 10.1016/j.msard.2018.11.012. Epub 2018 Nov 13.

PMID:
30469022
4.

Ecological impact of isolated cognitive relapses in MS.

Meli R, Roccatagliata L, Capello E, Bruschi N, Uccelli A, Mancardi G, Inglese M, Pardini M.

Mult Scler. 2018 Nov 15:1352458518813722. doi: 10.1177/1352458518813722. [Epub ahead of print]

PMID:
30430928
5.

Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ.

Massimi L, Bukreeva I, Santamaria G, Fratini M, Corbelli A, Brun F, Fumagalli S, Maugeri L, Pacureanu A, Cloetens P, Pieroni N, Fiordaliso F, Forloni G, Uccelli A, Kerlero de Rosbo N, Balducci C, Cedola A.

Neuroimage. 2019 Jan 1;184:490-495. doi: 10.1016/j.neuroimage.2018.09.044. Epub 2018 Sep 18.

PMID:
30240904
6.

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report.

Lapucci C, Gualandi F, Mikulska M, Palmeri S, Mancardi G, Uccelli A, Laroni A.

Mult Scler Relat Disord. 2018 Nov;26:52-54. doi: 10.1016/j.msard.2018.09.006. Epub 2018 Sep 11.

PMID:
30223229
7.

PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation.

Gianni-Barrera R, Butschkau A, Uccelli A, Certelli A, Valente P, Bartolomeo M, Groppa E, Burger MG, Hlushchuk R, Heberer M, Schaefer DJ, Gürke L, Djonov V, Vollmar B, Banfi A.

Angiogenesis. 2018 Nov;21(4):883-900. doi: 10.1007/s10456-018-9634-5. Epub 2018 Jul 16.

8.

Neurological manifestations in autoinflammatory diseases.

Uccelli A, Gattorno M.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):61-67. Epub 2018 May 3. Review.

9.

Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation.

Giordana MT, Cavalla P, Uccelli A, Laroni A, Bandini F, Vercellino M, Mancardi G.

Mult Scler. 2018 Jul;24(8):1133-1137. doi: 10.1177/1352458518763095. Epub 2018 Apr 30.

PMID:
29708466
10.

EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.

Groppa E, Brkic S, Uccelli A, Wirth G, Korpisalo-Pirinen P, Filippova M, Dasen B, Sacchi V, Muraro MG, Trani M, Reginato S, Gianni-Barrera R, Ylä-Herttuala S, Banfi A.

EMBO Rep. 2018 May;19(5). pii: e45054. doi: 10.15252/embr.201745054. Epub 2018 Apr 11.

11.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
12.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
13.

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, Longobardi S, Visconti A, Matarese G.

Metabolism. 2017 Dec;77:39-46. doi: 10.1016/j.metabol.2017.08.011. Epub 2017 Sep 8.

14.

Teriflunomide treatment reduces B cells in patients with MS.

Gandoglia I, Ivaldi F, Laroni A, Benvenuto F, Solaro C, Mancardi G, Kerlero de Rosbo N, Uccelli A.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e403. doi: 10.1212/NXI.0000000000000403. eCollection 2017 Nov.

15.

A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter.

Franciotta D, Uccelli A; Under the auspices of the Italian Association of Neuroimmunology (AINI).

Neurol Sci. 2017 Oct;38(Suppl 2):213-216. doi: 10.1007/s10072-017-3022-6. No abstract available.

PMID:
29030771
16.

Dramatic rebounds of MS during pregnancy following fingolimod withdrawal.

Novi G, Ghezzi A, Pizzorno M, Lapucci C, Bandini F, Annovazzi P, Mancardi GL, Uccelli A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 27;4(5):e377. doi: 10.1212/NXI.0000000000000377. eCollection 2017 Sep. No abstract available. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2018 Apr 12;5(3):e462.

17.

X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model.

Cedola A, Bravin A, Bukreeva I, Fratini M, Pacureanu A, Mittone A, Massimi L, Cloetens P, Coan P, Campi G, Spanò R, Brun F, Grigoryev V, Petrosino V, Venturi C, Mastrogiacomo M, Kerlero de Rosbo N, Uccelli A.

Sci Rep. 2017 Jul 19;7(1):5890. doi: 10.1038/s41598-017-06251-7.

18.

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS.

Bommarito G, Bellini A, Pardini M, Solaro C, Roccatagliata L, Laroni A, Capello E, Mancardi GL, Uccelli A, Inglese M.

Mult Scler. 2018 Apr;24(5):623-631. doi: 10.1177/1352458517704077. Epub 2017 Apr 10.

PMID:
28394195
19.

Quantitative 3D investigation of Neuronal network in mouse spinal cord model.

Bukreeva I, Campi G, Fratini M, Spanò R, Bucci D, Battaglia G, Giove F, Bravin A, Uccelli A, Venturi C, Mastrogiacomo M, Cedola A.

Sci Rep. 2017 Jan 23;7:41054. doi: 10.1038/srep41054.

20.

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.

Gross CC, Schulte-Mecklenbeck A, Wiendl H, Marcenaro E, Kerlero de Rosbo N, Uccelli A, Laroni A.

Front Immunol. 2016 Dec 19;7:606. doi: 10.3389/fimmu.2016.00606. eCollection 2016. Review.

21.

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction.

Tintoré M, Alexander M, Costello K, Duddy M, Jones DE, Law N, O'Neill G, Uccelli A, Weissert R, Wray S.

Patient Prefer Adherence. 2016 Dec 22;11:33-45. doi: 10.2147/PPA.S115090. eCollection 2017.

22.

In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.

Gandoglia I, Ivaldi F, Carrega P, Armentani E, Ferlazzo G, Mancardi G, Kerlero de Rosbo N, Uccelli A, Laroni A.

Immunol Lett. 2017 Jan;181:109-115. doi: 10.1016/j.imlet.2016.11.015. Epub 2016 Dec 2.

PMID:
27919749
23.

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.

Laroni A, Brogi D, Brescia Morra V, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL.

Neurol Sci. 2017 Jan;38(1):53-59. doi: 10.1007/s10072-016-2701-z. Epub 2016 Oct 18.

PMID:
27757552
24.

Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.

Massimi L, Fratini M, Bukreeva I, Brun F, Mittone A, Campi G, Spanò R, Mastrogiacomo M, de Rosbo NK, Bravin A, Uccelli A, Cedola A.

Phys Med. 2016 Dec;32(12):1779-1784. doi: 10.1016/j.ejmp.2016.09.015. Epub 2016 Oct 13.

PMID:
27743707
25.

IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways.

Vigo T, Procaccini C, Ferrara G, Baranzini S, Oksenberg JR, Matarese G, Diaspro A, Kerlero de Rosbo N, Uccelli A.

J Allergy Clin Immunol. 2017 May;139(5):1667-1676. doi: 10.1016/j.jaci.2016.09.004. Epub 2016 Sep 23.

PMID:
27670240
26.

Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.

Rozenberg A, Rezk A, Boivin MN, Darlington PJ, Nyirenda M, Li R, Jalili F, Winer R, Artsy EA, Uccelli A, Reese JS, Planchon SM, Cohen JA, Bar-Or A.

Stem Cells Transl Med. 2016 Nov;5(11):1506-1514. doi: 10.5966/sctm.2015-0243. Epub 2016 Jul 11.

27.

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.

Annovazzi P, Capobianco M, Moiola L, Patti F, Frau J, Uccelli A, Centonze D, Perini P, Tortorella C, Prosperini L, Lus G, Fuiani A, Falcini M, Martinelli V, Comi G, Ghezzi A.

J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.

PMID:
27286847
28.

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.

Laroni A, Armentani E, Kerlero de Rosbo N, Ivaldi F, Marcenaro E, Sivori S, Gandhi R, Weiner HL, Moretta A, Mancardi GL, Uccelli A.

J Autoimmun. 2016 Aug;72:8-18. doi: 10.1016/j.jaut.2016.04.003. Epub 2016 May 4.

29.

NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.

Ferrara G, Errede M, Girolamo F, Morando S, Ivaldi F, Panini N, Bendotti C, Perris R, Furlan R, Virgintino D, Kerlero de Rosbo N, Uccelli A.

Acta Neuropathol. 2016 Jul;132(1):23-42. doi: 10.1007/s00401-016-1563-z. Epub 2016 Mar 30.

30.

Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Mattioli F, Bellomi F, Stampatori C, Provinciali L, Compagnucci L, Uccelli A, Pardini M, Santuccio G, Fregonese G, Pattini M, Allegri B, Clerici R, Lattuada A, Montomoli C, Corso B, Gallo P, Riccardi A, Ghezzi A, Roscio M, Tola MR, Calanca C, Baldini D, Trafficante D, Capra R.

Front Behav Neurosci. 2016 Feb 23;10:28. doi: 10.3389/fnbeh.2016.00028. eCollection 2016.

31.

Sirt6 regulates dendritic cell differentiation, maturation, and function.

Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, Monacelli F, Odetti P, Ballestrero A, Uccelli A, Mostoslavsky R, Poggi A, Nencioni A.

Aging (Albany NY). 2016 Jan;8(1):34-49.

32.

Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.

Benvenuto F, Voci A, Carminati E, Gualandi F, Mancardi G, Uccelli A, Vergani L.

Stem Cell Res Ther. 2015 Dec 10;6:245. doi: 10.1186/s13287-015-0222-y.

33.

Mesenchymal stromal cells and immunity: Introductory overview.

Moretta L, Uccelli A, Pistoia V.

Immunol Lett. 2015 Dec;168(2):127-8. doi: 10.1016/j.imlet.2015.08.010. Epub 2015 Sep 2. No abstract available.

PMID:
26342805
34.

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection.

Laroni A, de Rosbo NK, Uccelli A.

Immunol Lett. 2015 Dec;168(2):183-90. doi: 10.1016/j.imlet.2015.08.007. Epub 2015 Aug 18. Review.

PMID:
26296458
35.

The immunomodulatory function of mesenchymal stem cells: mode of action and pathways.

Uccelli A, de Rosbo NK.

Ann N Y Acad Sci. 2015 Sep;1351:114-26. doi: 10.1111/nyas.12815. Epub 2015 Jul 6. Review.

PMID:
26152292
36.

Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.

Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, Usai C, Wipke BT, Scannevin RH, Mancardi GL, Centonze D, Kerlero de Rosbo N, Uccelli A.

Acta Neuropathol. 2015 Aug;130(2):279-95. doi: 10.1007/s00401-015-1422-3. Epub 2015 Apr 29.

37.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G.

Mult Scler. 2015 Jul;21(8):1013-24. doi: 10.1177/1352458514568827. Epub 2015 Feb 13.

PMID:
25680984
38.

A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study.

Mattioli F, Stampatori C, Bellomi F, Danni M, Compagnucci L, Uccelli A, Pardini M, Santuccio G, Fregonese G, Pattini M, Allegri B, Clerici R, Lattuada A, Montomoli C, Corso B, Capra R.

Front Neurol. 2015 Jan 13;5:278. doi: 10.3389/fneur.2014.00278. eCollection 2014.

39.

Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.

Curro' D, Vuolo L, Gualandi F, Bacigalupo A, Roccatagliata L, Capello E, Uccelli A, Saccardi R, Sormani MP, Mancardi G.

Mult Scler. 2015 Oct;21(11):1423-30. doi: 10.1177/1352458514564484. Epub 2015 Jan 12.

PMID:
25583838
40.

Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis.

Marinelli L, Mori L, Solaro C, Uccelli A, Pelosin E, Currà A, Molfetta L, Abbruzzese G, Trompetto C.

Mult Scler. 2015 Apr;21(5):622-9. doi: 10.1177/1352458514549566. Epub 2014 Sep 25.

PMID:
25257616
41.

Selective impairments of motor sequence learning in multiple sclerosis patients with minimal disability.

Tacchino A, Bove M, Roccatagliata L, Luigi Mancardi G, Uccelli A, Bonzano L.

Brain Res. 2014 Oct 17;1585:91-8. doi: 10.1016/j.brainres.2014.08.031. Epub 2014 Aug 20.

PMID:
25148706
42.

Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis.

Pardini M, Bonzano L, Bergamino M, Bommarito G, Feraco P, Murugavel A, Bove M, Brichetto G, Uccelli A, Mancardi G, Roccatagliata L.

Mult Scler. 2015 Apr;21(4):442-7. doi: 10.1177/1352458514546791. Epub 2014 Aug 21.

PMID:
25145692
43.

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.

Laroni A, Gandoglia I, Solaro C, Ribizzi G, Tassinari T, Pizzorno M, Parodi S, Baldassarre G, Rilla MT, Venturi S, Capello E, Sormani MP, Uccelli A, Mancardi GL.

BMC Neurol. 2014 May 12;14:103. doi: 10.1186/1471-2377-14-103.

44.

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.

Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL; EAP Investigators.

BMC Neurol. 2014 Apr 1;14:65. doi: 10.1186/1471-2377-14-65.

45.

Isolated cognitive relapses in multiple sclerosis.

Pardini M, Uccelli A, Grafman J, Yaldizli Ö, Mancardi G, Roccatagliata L.

J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1035-7. doi: 10.1136/jnnp-2013-307275. Epub 2014 Mar 31.

PMID:
24686566
46.

Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.

Di Prisco S, Merega E, Lanfranco M, Casazza S, Uccelli A, Pittaluga A.

Br J Pharmacol. 2014 May;171(9):2457-67. doi: 10.1111/bph.12631.

47.

Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.

Beninato T, Scognamiglio T, Kleiman DA, Uccelli A, Vaca D, Fahey TJ 3rd, Zarnegar R.

Surgery. 2013 Dec;154(6):1331-6; discussion 1336. doi: 10.1016/j.surg.2013.05.009.

PMID:
24238051
48.

Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.

Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N.

Immunology. 2014 Mar;141(3):328-39. doi: 10.1111/imm.12177. Review.

49.

CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.

Di Prisco S, Merega E, Milanese M, Summa M, Casazza S, Raffaghello L, Pistoia V, Uccelli A, Pittaluga A.

Neuropharmacology. 2013 Dec;75:337-46. doi: 10.1016/j.neuropharm.2013.07.037. Epub 2013 Aug 16.

PMID:
23958452
50.

Quantitative assessment of finger motor impairment in multiple sclerosis.

Bonzano L, Sormani MP, Tacchino A, Abate L, Lapucci C, Mancardi GL, Uccelli A, Bove M.

PLoS One. 2013 May 31;8(5):e65225. doi: 10.1371/journal.pone.0065225. Print 2013.

Supplemental Content

Loading ...
Support Center